Balaxi Pharma Q1 results FY27: revenue Rs 80 Cr (+14.05% YoY), PAT Rs 1 Cr. Financial highlights, analysis and FY27 outlook for the June 2026 quarter.

Aspinwall and Company Q1 results FY27: revenue Rs 113 Cr (+25.76% YoY), net loss Rs 70 Lakh. Financial highlights, analysis and FY27 outlook for the June 2026 quarter.

Modulex Constructions Q1 results FY27: revenue Rs 0 Cr (NA YoY), net loss Rs 4 Cr. Financial highlights, analysis and FY27 outlook for the June 2026 quarter.

Aster DM Healthcare Q1 results FY27: revenue Rs 1,310 Cr (+21.60% YoY), PAT Rs 37 Cr. Financial highlights, analysis and FY27 outlook for the June 2026 quarter.

Page Industries vs Rupa and Company compared on brand strength, dealer network, ROE and valuation. Full data-backed breakdown for innerwear investors.

Biocon Q1 results FY27: revenue Rs 4,336 Cr (+10.00% YoY), PAT Rs 136 Cr. Financial highlights, analysis and FY27 outlook for the June 2026 quarter.

Bikaji Foods vs Prataap Snacks compared on brand strength, geographic reach, margins and valuation. Full data-backed breakdown for ethnic snack investors.

Hindalco share pros and cons: aluminium giant with Novelis EV tailwind analysed for 2026. Covers global aluminium leadership, EV lightweighting demand, commodity risks, and PE valuation.

Cummins India Q1 results FY27: revenue Rs 3,426 Cr (+17.86% YoY), PAT Rs 519 Cr. Financial highlights, analysis and FY27 outlook for the June 2026 quarter.

IndiGo share pros and cons: India’s airline monopoly analysed for 2026. 60 percent market share, crude oil risks, engine groundings, and India aviation growth story covered.